Hawkins (HWKN) came out with quarterly earnings of $1.4 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.38 per share a year ago.
HWKN acquires PhillTech to strengthen its water treatment business and expand its coagulants production.
HWKN hits a 52-week high as earnings estimates rise and Water Treatment expansion powers strong revenue growth.
HWKN's rising earnings estimates and momentum in Water Treatment signal strong upside potential ahead.
Hawkins (HWKN) possesses solid growth attributes, which could help it handily outperform the market.
Hawkins (HWKN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.66 per share a year ago.
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does Hawkins (HWKN) have what it takes to be a top stock pick for momentum investors? Let's find out.
HWKN's Water Treatment unit benefits from added sales from acquired businesses and higher sales volumes in the legacy business in Q3.
Defying today's market downturn, water treatment company Hawkins (HWKN 5.41%) saw its shares move higher on Monday after announcing it has acquired all the assets of rival water treatment chemicals and equipment company Amerochem.
Thursday was a good day for many stocks. However, Hawkins (HWKN -8.44%) wasn't one of those winners.
Hawkins (HWKN) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.71 per share a year ago.